Entrada Therapeutics Inc (TRDA)
EBITDA Margin
-4664.48%
Quarterly · Period ending:
TRDA EBITDA Margin
Latest reported-4664.48%period ending
Latest reported-4664.48%period ending
TRDA Quarterly EBITDA Margin (0.00% → -4664.48%)
Quarterly ebitda margin
High-resolution chart · PNG
TRDA ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -4,664.4766% | |
| -4,442.7429% | |
| -3,222.2479% | |
| -2,617.72% | |
| -2,148.2564% | |
| -79.7889% | |
| 0.6765% | |
| -76.418% | |
| 61.9881% | |
| 44.4198% | |
| 23.7359% | |
| 122.7689% | |
| -62.4711% | |
| -10.2217% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |